Evaluation of HER2-based biology in 1,006 cases of gastric cancer in a Japanese population.
about
Gastric biomarkers: a global reviewPerspectives on new biomarkers in gastric cancer: diagnostic and prognostic applicationsDepth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumabClinical impact of tumour biology in the management of gastroesophageal cancerTSPAN8, identified by Escherichia coli ampicillin secretion trap, is associated with cell growth and invasion in gastric cancer.Correlation between apparent diffusion coefficients and HER2 status in gastric cancers: pilot study.Overexpression of Transmembrane Protein BST2 is Associated with Poor Survival of Patients with Esophageal, Gastric, or Colorectal Cancer.Prognostic Role of Primary Tumor Location in Non-Metastatic Gastric Cancer: A Systematic Review and Meta-Analysis of 50 Studies.The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literatureClinical utility of HER2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer.FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre studyCorrelation between human epidermal growth factor receptor 2 expression level and efficacy of trastuzumab beyond progression in metastatic gastric cancerTrastuzumab Inhibits Growth of HER2-Negative Gastric Cancer Cells Through Gastrin-Initialized CCKBR Signaling.Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology.Role of intravoxel incoherent motion MR imaging in preoperative assessing HER2 status of gastric cancers.Gene copy number gain of EGFR is a poor prognostic biomarker in gastric cancer: evaluation of 855 patients with bright-field dual in situ hybridization (DISH) method.Prognostic significance of HER2 expression based on trastuzumab for gastric cancer (ToGA) criteria in gastric cancer: an updated meta-analysis.Predictive factors of trastuzumab-based chemotherapy in HER2 positive advanced gastric cancer: a single-center prospective observational study.Impact of HER2 expression on outcome in gastric cancer patients with liver metastasis.Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer.Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma.Is "liquid biopsy" useful for assessing HER2 status in gastric cancer?Incorporation of p-53 mutation status and Ki-67 proliferating index in classifying Her2-neu positive gastric adenocarcinoma.Establishment and validation of prognostic nomograms in first-line metastatic gastric cancer patients.
P2860
Q26741859-F92AFD1D-46CB-458A-A476-621D3F9A834BQ27012898-3D66BA9F-E710-45BF-8CB0-5F0386AB832CQ33761681-0104128A-56C2-4E11-A7D2-EFB3402034E9Q33922534-3613D160-656E-4A87-BA81-E63540EEE087Q35567175-33C68951-F4FF-4B41-838A-CBECF9188D83Q35815603-5C443F15-72FB-457E-B86F-48D6CE1F7B1AQ35911232-92C4BC58-4C23-4EB2-B801-39DF6798F0E7Q36309934-3162A75D-80AF-4B9F-960A-71622BD07D6CQ36317603-9BB16F8F-5C1D-4480-9F35-40C1C9928B6EQ36648866-127979AB-CAA3-414E-9222-6830CD9F4265Q37594375-E7C35684-6F8A-494E-8BE5-09499E5B703AQ38637978-9980E286-35FB-4C84-BCB7-811C4E46831AQ38853156-FE56C192-0B13-4025-8C07-1D343E18C7AFQ39038837-A02C3B05-1AD1-4000-89D2-531C7BB5F351Q39080349-AB5DAED4-1A8A-48E6-A052-637455F7C57DQ41472425-178AE4BA-77C8-4DF2-AAC8-55C758542B37Q41714879-351B3158-08CF-4883-8F34-DEE32E133631Q43479667-6036C1C7-3173-48E1-8D07-DBBEA23D2C5EQ47425148-A43F661C-34E8-4706-AE9F-B839C7A23C32Q47764668-D3F88CF8-DC74-4059-B0B5-CAE402FBEC25Q48379063-4CEF7A6D-37AE-4EAD-ADA4-E0BFECFD9616Q54218339-6CD6F4E8-0051-4BEA-933A-CD487A22FFD5Q54352853-08240B94-E9A8-4309-9009-56880CCDC61AQ55264153-C3B16F71-BEBA-40C2-B152-541F89298DC5Q55338874-EFB7DF4F-81DD-445A-9516-A56C88D05A5A
P2860
Evaluation of HER2-based biology in 1,006 cases of gastric cancer in a Japanese population.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Evaluation of HER2-based biolo ...... ncer in a Japanese population.
@en
type
label
Evaluation of HER2-based biolo ...... ncer in a Japanese population.
@en
prefLabel
Evaluation of HER2-based biolo ...... ncer in a Japanese population.
@en
P2093
P1433
P1476
Evaluation of HER2-based biolo ...... ncer in a Japanese population.
@en
P2093
Akiko K Nagatsuma
Atsushi Ochiai
Koji Kitada
Masaki Aizawa
Satoshi Fujii
Taira Kinoshita
Takeshi Kuwata
P2888
P356
10.1007/S10120-013-0239-9
P577
2013-02-22T00:00:00Z
P5875
P6179
1022161825